<--- Back to Details
First PageDocument Content
Medicine / Pharmacology / Drug safety / Pharmaceutical industry / Pharmaceuticals policy / Pharmacovigilance / EudraVigilance / European Medicines Agency / Adverse effect / Health / Pharmaceutical sciences / Clinical research
Date: 2014-09-15 04:34:45
Medicine
Pharmacology
Drug safety
Pharmaceutical industry
Pharmaceuticals policy
Pharmacovigilance
EudraVigilance
European Medicines Agency
Adverse effect
Health
Pharmaceutical sciences
Clinical research

03 GVP Module ICSR - Superseeded

Add to Reading List

Source URL: www.ema.europa.eu

Download Document from Source Website

File Size: 998,53 KB

Share Document on Facebook

Similar Documents

The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Inspections EMEA/CVMPFINAL COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

DocID: 1vrLd - View Document

7 May 2018 EMAHuman Medicines Research and Development Support Division European Medicines Agency Guidance for applicants seeking access to PRIME scheme

DocID: 1vlIp - View Document

The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use London, 23 January 2003 CPMP/SWP

DocID: 1ucvu - View Document

2 March 2016 EMAExternal guidance on the implementation of the European Medicines Agency policy on the publication of clinical data for medicinal products for human use

DocID: 1sVev - View Document

European Medicines Agency: Celebrating 20 years

DocID: 1sUY9 - View Document